Otsuka Holdings Co., Ltd. Logo

Otsuka Holdings Co., Ltd.

Global healthcare group creating pharmaceuticals and nutraceuticals for worldwide well-being.

4578 | T

Overview

Corporate Details

ISIN(s):
JP3188220002
LEI:
Country:
Japan
Address:
千代田区神田司町2−9
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Otsuka Holdings Co., Ltd. is a global healthcare group operating under the corporate philosophy of 'Otsuka-people creating new products for better health worldwide.' The company's operations are centered around two core segments: the Pharmaceutical Business and the Nutraceutical Business. The Pharmaceutical division focuses on the research, development, manufacturing, and sale of innovative products for the diagnosis and treatment of diseases, with a strong presence in areas such as central nervous system disorders, oncology, and cardiovascular diseases. The Nutraceutical division provides products that support daily health maintenance and improvement, including functional foods and beverages like POCARI SWEAT and SOYJOY, as well as 'Cosmedics' (cosmetics + medicine). The group is committed to a holistic approach to health, creating highly original products to contribute to the well-being of people globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-31 09:22
Report Publication Announcement
確認書
Japanese 8.3 KB
2025-07-31 09:21
Interim Report
半期報告書-第18期(2025/01/01-2025/12/31)
Japanese 340.0 KB
2025-05-22 03:58
Registration Form
発行登録追補書類(株券、社債券等)
Japanese 101.5 KB
2025-05-12 06:10
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.1 KB
2025-05-08 09:07
Prospectus
発行登録書(株券、社債券等)
Japanese 26.0 KB
2025-05-07 09:48
Major Shareholding Notification
臨時報告書
Japanese 21.0 KB
2025-05-02 09:29
M&A Activity
訂正臨時報告書
Japanese 29.3 KB
2025-04-14 09:03
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.6 KB
2025-04-01 09:00
Post-Annual General Meeting Information
臨時報告書
Japanese 25.5 KB
2025-04-01 09:00
Share Issue/Capital Change
臨時報告書
Japanese 41.6 KB
2025-03-31 04:06
Registration Form
確認書
Japanese 8.3 KB
2025-03-31 04:05
Governance Information
内部統制報告書-第17期(2024/01/01-2024/12/31)
Japanese 23.9 KB
2025-03-31 04:04
Annual Report
有価証券報告書-第17期(2024/01/01-2024/12/31)
Japanese 3.3 MB
2025-03-21 08:16
Major Shareholding Notification
臨時報告書
Japanese 20.7 KB
2025-03-14 08:09
M&A Activity
訂正臨時報告書
Japanese 26.2 KB

Automate Your Workflow. Get a real-time feed of all Otsuka Holdings Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Otsuka Holdings Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Otsuka Holdings Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
Develops mRNA therapeutics and vaccines for rare respiratory, liver, and infectious diseases.
United States of America
ARCT
Arcus Biosciences, Inc. Logo
A clinical-stage biopharma developing small molecule and antibody combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes non-steroidal therapies for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharma developing first-in-class drugs for cardiorenal and GI diseases like IBS-C and CKD.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom
AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Developing bacteriophage therapeutics for antibiotic-resistant infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.
United States of America
AVBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.